Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05361902
What this trial is testing

A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
Erasmus Medical Center 35
Not applicableStudy completedNCT04324983
What this trial is testing

Identification of Predictive Biomarkers

Who this might be right for
Prostate Cancer Recurrent
Martini-Klinik am UKE GmbH 150
Not applicableStudy completedNCT00499694
What this trial is testing

Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 31
Testing effectiveness (Phase 2)Study completedNCT05653856
What this trial is testing

Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate Cancer

Who this might be right for
Metastasis From Malignant Tumor of Prostate (Disorder)
Curium US LLC 26
Testing effectiveness (Phase 2)Study completedNCT01807065
What this trial is testing

Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateBone MetastasesHormone-resistant Prostate Cancer+3 more
City of Hope Medical Center 51
Testing effectiveness (Phase 2)Study completedNCT00003400
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Maryland, Baltimore 45
Testing effectiveness (Phase 2)Study completedNCT00090545
What this trial is testing

A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Looking for participantsNCT07224009
What this trial is testing

Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)

Who this might be right for
Metastatic Prostate Cancer
University of Arkansas 60
Testing effectiveness (Phase 2)Ended earlyNCT00104130
What this trial is testing

Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb 53
Testing effectiveness (Phase 2)Study completedNCT01784913
What this trial is testing

A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Ultimovacs ASA 22
Large-scale testing (Phase 3)Study completedNCT01809691
What this trial is testing

S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 1,313
Not applicableLooking for participantsNCT06762379
What this trial is testing

Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration

Who this might be right for
Metastatic Prostate Cancer (mPC)
European Institute of Oncology 125
Testing effectiveness (Phase 2)Ended earlyNCT03815942
What this trial is testing

VAccination in Early and ADvanced Prostate caNCEr

Who this might be right for
Intermediate Risk Prostate CancerCastration-resistant Prostate Cancer
University of Oxford 23
Post-approval studies (Phase 4)UnknownNCT03202381
What this trial is testing

Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix

Who this might be right for
Prostate Cancer
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 35
Large-scale testing (Phase 3)UnknownNCT03119857
What this trial is testing

Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14

Who this might be right for
Prostatic Neoplasms
Göteborg University 349
Testing effectiveness (Phase 2)Study completedNCT00331344
What this trial is testing

Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Study completedNCT00748358
What this trial is testing

An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic NeoplasmsNeoplasms, Hormone-DependentTumor Markers, Biological+2 more
Assistance Publique - Hôpitaux de Paris 50
Large-scale testing (Phase 3)Study completedNCT00003343
What this trial is testing

Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Pfizer 525
Large-scale testing (Phase 3)Study completedNCT00673205
What this trial is testing

(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer

Who this might be right for
Non-Metastatic Prostate Cancer
AstraZeneca 3,588
Not applicableNot Yet RecruitingNCT07484269
What this trial is testing

PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan

Who this might be right for
Metastatic Prostate Cancer
Novartis Pharmaceuticals 753
Next Page